Larvol Delta - SON080-in-Patients-With-Persistent-Chemotherapyinduced-Peripheral-Neuropathy-CIPN

SON-1010 - Sonnet BioTherap

https://www.globenewswire.com/en/news-release/2024/09/18/2948188/0/en/Sonnet-BioTherapeutics-Completes-Enrollment-in-Phase-1-Study-of-SON-1010-IL12-FHAB-as-a-Monotherapy-SB101-for-the-Treatment-of-Solid-Tumors.html

Sep 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next